Questions discussed in this category
Assuming other non CTD related causes for PAH have been excluded
How do you risk stratify and monitor such patient for disease progression or organ involvement?
If so, what test do you use in clinical practice?
12720126121177410282878877637836773978517323
Papers discussed in this category
RMD open, 2015
Annals of the rheumatic diseases, 1999-04
Arthritis Care Res (Hoboken),
Rheumatology (Oxford), 2020 Feb 11
Multiple sclerosis (Houndmills, Basingstoke, England), 2014-01
Ann. Neurol., 2018 Feb 15
J Am Dent Assoc,
Arthritis Rheumatol, 2016 Oct 26
Ann Rheum Dis, 2019 Oct 31
Rheumatology (Oxford),
Rheumatology (Oxford), 2019 Mar 05
Chest, 2021 Feb
Muscle & nerve, 2007-01
Annals of neurology, 1990-03
Rheum Dis Clin North Am, 2017 Aug 23
Neurology,
Medicine (Baltimore),
Muscle Nerve, 2014 Dec 23